Efficacy and Safety of Deferasirox (Exjade (R)) in Preventing Cardiac Iron Overload in beta-Thalassemia Patients with Normal Baseline Cardiac Iron: Results from the Cardiac Substudy of the EPIC Trial için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Efficacy and Safety of Deferasirox (Exjade (R)) in Preventing Cardiac Iron Overload in beta-Thalassemia Patients with Normal Baseline Cardiac Iron: Results from the Cardiac Substudy of the EPIC Trial | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
| Haziran 2025 | 0 |
| Temmuz 2025 | 0 |
